2,236 press releases in English indexed under biotech & pharma.
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.
Paradigm uses OpenAI’s API to improve patient access to clinical trials.
Abstract Some machine learning applications involve training data that is sensitive, such as the medical histories of patients in a clinical trial. A model may inadvertently and implicitly store some of its training data; careful analysis of the model may therefore reveal sensitive information. To address this problem, we demonstrate a generally applicable approach to providing strong privacy guarantees for training